Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1941846

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941846

North America IV Hydration Therapy Market Size, Share & Trends Analysis Report By Service (Immune Boosters, Energy Boosters), By Component (Medicated, Non-medicated), By Provider Type, By End Use, By Country, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

North America IV Hydration Therapy Market Summary

The North America IV hydration therapy market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.56 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The market is primarily driven by heightened consumer emphasis on proactive health management, the shift toward preventive wellness, and increasing demand for convenient, on-demand healthcare services.

Post-pandemic health consciousness has significantly accelerated the adoption of intravenous (IV) hydration as a lifestyle and recovery solution. In parallel, the growing incidence of fatigue, migraines, and nutrient deficiencies has expanded the therapeutic scope of IV therapy beyond traditional clinical use.

The North America IV hydration therapy industry is rising, owing to the increasing prevalence of chronic diseases such as cancer and diabetes. According to the CDC estimates of February 2024, around 129 million people in the US have at least 1 major chronic disease, creating a strong demand for effective healthcare solutions. IV hydration therapy is a crucial player, offering a direct and quick way to address the consequences and management of chronic diseases. It becomes a valuable tool in improving the well-being of individuals facing these conditions. As chronic diseases become more common, the market is stepping up to provide specialized care and support for those who need it.

Increasing awareness of the benefits of IV hydration therapies among North America's population is boosting the market growth. According to the National Institute of Health and Care Excellence, numerous adult patients require Intravenous (IV) fluid therapy to address to fluid and electrolyte balance. IV therapy is a therapeutic intervention that delivers fluids directly into the bloodstream to restore hydration and revitalize the body. Remarkably, IV hydration offers a faster and more complete absorption of vitamins, electrolytes, and antioxidants than oral intake, as it avoids the digestive system.

IV hydration therapy is utilized across multiple clinical areas to ensure rapid and effective fluid and electrolyte management. In emergency and critical care, it provides immediate resuscitation for trauma, shock, sepsis, and acute dehydration. For gastrointestinal disorders, it helps manage fluid loss from severe vomiting, diarrhea, or inflammatory bowel conditions. Post-surgical care relies on IV therapy to maintain fluid balance, deliver medications, and support recovery when oral intake is limited. In oncology, it prevents dehydration and fatigue during chemotherapy and radiation, while in chronic disease management, it supports patients with diabetes, renal, or cardiovascular conditions who have restricted oral intake.

The increasing demand for IV hydration therapy is also driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients' homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.

North America IV Hydration Therapy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America IV hydration therapymarket report based on service, component, provider type, end use, and regions.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Immune Boosters
  • Energy Boosters
  • Hydration
  • Beauty/ Aesthetics
  • Detoxification
  • Longevity/ Antiaging
  • Performance/ Athletics
  • Migraine & Pain Relief
  • Stress/Sleep/Mood Support
  • Flu/Stomach
  • Others
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Medicated
  • Non-medicated
  • Provider Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Mobile Providers
  • Physical Providers
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Wellness Centers and Spas
  • Home Healthcare
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • U.S.
  • Canada
  • Mexico
Product Code: GVR-4-68040-161-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Component
    • 1.2.3. Provider Type
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for quick rehydration and recovery solutions
      • 3.2.1.2. Increasing adoption of wellness and preventive healthcare trends
      • 3.2.1.3. Rising popularity of IV nutrient therapy for beauty, skin rejuvenation, and anti-aging benefits
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Risk of side effects, including infections, vein inflammation, or allergic reactions
      • 3.2.2.2. High cost of treatments compared to oral supplements and conventional care
      • 3.2.2.3. Limited insurance coverage, making therapies less accessible to many patients
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Pricing Analysis
    • 3.2.6. Emerging Trends
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. North America IV Hydration Therapy Market: Service Estimates & Trend Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Service Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Immune Boosters
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Energy Boosters
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hydration
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Beauty/ Aesthetics
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Detoxification
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Longevity/ Antiaging
    • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Performance/ Athletics
    • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Migraine & Pain Relief
    • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Stress/Sleep/Mood Support
    • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Flu/Stomach
    • 4.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America IV Hydration Therapy Market: Component Estimates & Trend Analysis

  • 5.1. Component Segment Dashboard
  • 5.2. Component Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 5.4. Medicated
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Medicated
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America IV Hydration Therapy Market: Provider Type Estimates & Trend Analysis

  • 6.1. Provider Type Dashboard
  • 6.2. Provider Type Market Share Movement Analysis, 2025& 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Provider Type, 2021 to 2033 (USD Million)
  • 6.4. Mobile Providers
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Physical Providers
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. North America IV Hydration Therapy Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Healthcare Providers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Wellness Centers & Spas
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Home Healthcare
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. North America IV Hydration Therapy Market: Country Estimates & Trend Analysis

  • 8.1. Country Market Dashboard
  • 8.2. Country Market: Key Takeaways
  • 8.3. U.S.
    • 8.3.1. Key country dynamic
    • 8.3.2. Regulatory framework
    • 8.3.3. Competitive insights
    • 8.3.4. U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Canada
    • 8.4.1. Key country dynamic
    • 8.4.2. Regulatory framework
    • 8.4.3. Competitive insights
    • 8.4.4. Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Mexico
    • 8.5.1. Key country dynamic
    • 8.5.2. Regulatory framework
    • 8.5.3. Competitive insights
    • 8.5.4. Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Baxter
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. B. Braun SE
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Otsuka Pharmaceutical Co., Ltd.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols, S.A.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Vifor Pharma Management Ltd.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. JW Life Science Corporation
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Amanta Healthcare
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. NexGen Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Core IV Therapy, LLC
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Drip Hydration
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. REVIV
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. DriPros IV Hydration Wellness
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. wHydrate
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Renew Ketamine & Wellness Center
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. R2 Medical Clinic
      • 9.5.15.1. Overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. AliveDrip
      • 9.5.16.1. Overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. Hydrate IV
      • 9.5.17.1. Overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Hydration Room
      • 9.5.18.1. Overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product benchmarking
      • 9.5.18.4. Strategic initiatives
Product Code: GVR-4-68040-161-3

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America IV Hydration Therapy market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 5 North America IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 6 North America IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 7 North America IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 9 U.S. IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 10 U.S. IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 11 U.S. IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 13 Canada IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 14 Canada IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 15 Canada IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico IV Hydration Therapy market, by component, 2021 - 2033 (USD Million)
  • Table 17 Mexico IV Hydration Therapy market, by service, 2021 - 2033 (USD Million)
  • Table 18 Mexico IV Hydration Therapy market, by provider type, 2021 - 2033 (USD Million)
  • Table 19 Mexico IV Hydration Therapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 North America IV Hydration Therapy market: Market outlook
  • Fig. 5 North America IV Hydration Therapy market: Segment outlook
  • Fig. 6 North America IV Hydration Therapy market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 North America IV Hydration Therapy Market Driver Impact
  • Fig. 9 North America IV Hydration Therapy market Restraint impact
  • Fig. 10 North America IV Hydration Therapy market, Service outlook key takeaways (USD Million)
  • Fig. 11 North America IV Hydration Therapy market: Service movement analysis (USD Million)
  • Fig. 12 Immune Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Energy Boosters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hydration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Beauty/ Aesthetics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Detoxification market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Longevity/ Antiaging market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Performance/ Athletics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Migraine & Pain Relief market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Stress/Sleep/Mood Support market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Flu/Stomach market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 North America IV Hydration Therapy market, component outlook: Key takeaways, (USD Million)
  • Fig. 24 North America IV Hydration Therapy market: component movement analysis, (USD Million)
  • Fig. 25 Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Medicated market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 North America IV Hydration Therapy market, provider type outlook key takeaways (USD Million)
  • Fig. 28 North America IV Hydration Therapy market: provider type movement analysis, (USD Million)
  • Fig. 29 Mobile Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Physical Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 North America IV Hydration Therapy market, end use outlook key takeaways (USD Million)
  • Fig. 32 North America IV Hydration Therapy market: end use movement analysis, (USD Million)
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Wellness Centers & Spas market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Home Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Country marketplace: Key takeaways
  • Fig. 38 North America IV Hydration Therapy market: Country outlook, 2025 & 2033
  • Fig. 39 U.S. IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Canada IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico IV Hydration Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!